Tekla Capital Management LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,133,000
-9.7%
529,2260.0%0.17%
-14.8%
Q1 2021$5,684,000
-52.8%
529,226
-35.3%
0.20%
-53.7%
Q4 2020$12,030,000
+88.9%
817,784
+82.5%
0.42%
+77.0%
Q3 2020$6,367,000
+75.6%
448,0490.0%0.24%
+73.2%
Q2 2020$3,625,000
+100.3%
448,0490.0%0.14%
+68.3%
Q1 2020$1,810,000
+294.3%
448,049
+0.4%
0.08%
+382.4%
Q4 2019$459,000
+235.0%
446,0990.0%0.02%
+183.3%
Q3 2019$137,000
-6.2%
446,0990.0%0.01%0.0%
Q2 2019$146,000
-50.3%
446,0990.0%0.01%
-50.0%
Q1 2019$294,000
-61.5%
446,0990.0%0.01%
-63.6%
Q4 2018$763,000
-71.9%
446,099
-4.8%
0.03%
-66.7%
Q3 2018$2,717,000
-3.3%
468,3990.0%0.10%
-7.5%
Q2 2018$2,810,000
-16.7%
468,3990.0%0.11%
-18.3%
Q1 2018$3,372,000
+2.6%
468,399
+4.1%
0.13%
+3.1%
Q4 2017$3,285,000
+27.6%
450,000
-10.0%
0.13%
+38.0%
Q3 2017$2,575,000
+30.1%
500,0000.0%0.09%
+26.0%
Q2 2017$1,980,000
+133.8%
500,000
+669.2%
0.07%
+143.3%
Q3 2015$847,000
-40.3%
65,0000.0%0.03%
-41.2%
Q2 2015$1,418,00065,0000.05%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders